⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRNX News
Crinetics Pharmaceuticals, Inc.
Vertex to Acquire Crinetics Pharmaceuticals
businesswire.com
VRTX
CRNX
Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 4, 2026
globenewswire.com
CRNX
Form 8-K
sec.gov
CRNX
Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026
globenewswire.com
CRNX
Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
globenewswire.com
CRNX
Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities
globenewswire.com
CRNX
Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations
globenewswire.com
CRNX
Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026
globenewswire.com
CRNX
Form 8-K
sec.gov
CRNX
Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
CRNX